[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-358982-105":59,"doc-detail-358982-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","noncoding-rnas-in-pediatric-solid-tumors-advances-in-understanding-and-critical-knowledge-gaps","Noncoding RNAs in Pediatric Solid Tumors: Advances in Understanding and Critical Knowledge Gaps","","Pediatric cancer etiology reflects developmental dysregulation rather than carcinogenic exposure–driven acquired mutations, producing distinct genetic and epigenetic landscapes and tissue microenvironments. Many pediatric cancers show limited progress in overall and event-free survival, creating a need for deeper investigation into underlying mechanisms. Non-coding RNAs regulate gene expression across epigenetic, transcriptional, and translational levels and can act as biomarkers. The review synthesizes evidence on microRNAs, long non-coding RNAs, and circular RNAs in onset, progression, and therapeutic response, evaluating therapeutic and biomarker potential while identifying critical knowledge gaps that could improve clinical outcomes.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/noncoding-rnas-in-pediatric-solid-tumors-advances-in-understanding-and-critical-knowledge-gaps/358982/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/noncoding-rnas-in-pediatric-solid-tumors-advances-in-understanding-and-critical-knowledge-gaps/358982.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is pediatric cancer etiology considered distinct from adult cancers?","Question",{"text":113,"@type":114},"Pediatric cancers stem from developmental dysregulation, producing characteristic genetic and epigenetic alterations and specific tissue microenvironments rather than acquired mutations from carcinogenic exposure.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which types of non-coding RNAs are covered in the review?",{"text":118,"@type":114},"The review focuses on microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), examining their roles in pediatric solid tumors.",{"name":120,"@type":111,"acceptedAnswer":121},"How might non-coding RNAs be used clinically according to the document?",{"text":122,"@type":114},"They can regulate oncogenic pathways and serve as potential therapeutic targets and biomarkers for disease subtype and/or stage, with emphasis on both current evidence and future challenges.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},358982,1790205230,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Review  \nNoncoding RNAs in Pediatric Solid Tumors: Advances in Understanding and Critical Knowledge Gaps  \nGraham Duff 1, Christine Mella 2, Alexa Amato-Loudon 2,3, Meredith Farrell 2,4, Rachael Aldridge 2,5 and Hope C. Ball 2,4,6, *  \nAcademic Editor: Tong-Chuan He  \nReceived: 26 January 2026  \nRevised: 26 February 2026  \nAccepted: 3 March 2026  \nPublished: 5 March 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Biology, The University of Akron, 302 Buchtel Common, Akron, OH 44325, USA; [grahamduff01@gmail.com](grahamduff01@gmail.com)  \n2 Division of Hematology Oncology, Akron Children’s Hospital, One Perkins Square, Akron, OH 44308, USA; [cmella@akronchildrens.org](cmella@akronchildrens.org) (C.M.); [aa324317@ohio.edu](aa324317@ohio.edu) (A.A.-L.); [mferrel@neomed.edu](mferrel@neomed.edu) (M.F.); [rachael.aldridge@live.mercer.edu](rachael.aldridge@live.mercer.edu) (R.A.)  \n3 Heritage College of Osteopathic Medicine, Ohio University, 191 West Union Street, Athens, OH 45701, USA  \n4 College of Medicine, Northeast Ohio Medical University, 4029 State Route 44, Rootstown, OH 44272, USA  \n5 College of Medicine, Mercer University School of Medicine, 1550 College St., Macon, GA 31207, USA  \n6 Rebecca D. Considine Research Institute, Akron Children’s Hospital, One Perkins Square, Akron, OH 44308, USA  \n* [Correspondence: hball@akronchildrens.org](Correspondence: hball@akronchildrens.org)  \nAbstract  \nThe etiology of pediatric cancers is unique, stemming from developmental dysregulation rather than acquired mutations from carcinogenic exposure. These diseases demonstrate vastly different underlying genetic and epigenetic alterations and unique tissue microenvironments which are only now beginning tobe explored. While many pediatric cancers have seen improved overall and event-free survival rates thanks to innovations in diagnosis and treatment, many have seen little to no improvement in patient outcomes. This highlights a critical need for additional research into the underlying genetic and epigenetic alterationsin these pathologies. Non-coding RNAs (ncRNAs) are functional RNA molecules known to regulate gene expression at epigenetic, transcriptional, and translational levels and can serve as biomarkers of disease. Here, we examine current knowledge of the roles of microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs) in the onset, progression, and therapeutic response of pediatric solid tumors. We discuss the current and future potential and pitfalls of these molecules as therapeutics and biomarkers and highlight critical knowledge gaps where future research might provide insight to improve current therapeutic strategies and improve clinical outcomes.  \nKeywords: non-coding RNA; epigenetics; pediatrics; cancer; solid tumors; drug resistance  \n1. Introduction  \nCancer affects both adult and pediatric patient populations and is a major global socioeconomic health problem [1,2] . Adult cancers often arise from accumulated genetic and/or epigenetic mutations affecting epithelial cell transcription/translation, cycle regulation, or DNA damage repair mechanisms [3,4] . The etiology of pediatric cancers, however, lies in the developmental dysregulation of mesoderm-, ectoderm-, or endoderm-originating cells, resulting in fusion genes or oncogenic changes in stem cell populations or the tissue microenvironment (TME) [5–7] . Furthermore, the pediatric cancer-associated gene mutations are significantly different from adult-onset counterparts, and the mechanisms of disease onset, metastasis, and therapeutic response remain poorly understood.  \nIn the pediatric population, cancer stands as the second leading cause of death, second only to injury-related mortalities [8,9] . Solid tumors comprise around 60% of all diagnosed pediatric cancers an","cbCailHlcaUaWRhK","https://ap.wps.com/l/cbCailHlcaUaWRhK","pdf",1345382,34,"English","# Abstract\n# 1. Introduction\n# 2. Materials and Methods","[{\"question\":\"Why is pediatric cancer etiology considered distinct from adult cancers?\",\"answer\":\"Pediatric cancers stem from developmental dysregulation, producing characteristic genetic and epigenetic alterations and specific tissue microenvironments rather than acquired mutations from carcinogenic exposure.\"},{\"question\":\"Which types of non-coding RNAs are covered in the review?\",\"answer\":\"The review focuses on microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), examining their roles in pediatric solid tumors.\"},{\"question\":\"How might non-coding RNAs be used clinically according to the document?\",\"answer\":\"They can regulate oncogenic pathways and serve as potential therapeutic targets and biomarkers for disease subtype and/or stage, with emphasis on both current evidence and future challenges.\"}]","Noncoding RNAs in Pediatric Solid Tumors: Advances in Understanding and Critical Knowledge Gaps | PDF",1790135800,86,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3f3c702e385da938ef580bbce9a62fe5.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db834cb3b0cacf4c1e2dc11802541982.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1243dd11d00305ed573d0422ad8aafb9.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/20219b8823832e907db7127dbfa1d621.webp",980,1385]